Literature DB >> 30944188

Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions.

Johanna Sandlund1, Mark H Wilcox2.   

Abstract

The use of nucleic acid amplification tests (NAATs) for the diagnosis of Clostridium (Clostridioides) difficile infection (CDI) leads to overdiagnosis. To improve the clinical specificity of NAATs, there has been a recent interest in using toxin gene cycle thresholds (CT s) to predict the presence and absence of toxins. Although there is an association between CT values and fecal toxin concentrations, the predictive accuracy of the former is suboptimal for use in clinical practice. Ultrasensitive toxin immunoassays to quantify free toxins in stool offer a novel option for high-sensitivity fecal toxin detection rather than using surrogate markers for prediction.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  CT value; Clostridium difficile; toxin

Mesh:

Substances:

Year:  2019        PMID: 30944188      PMCID: PMC6535589          DOI: 10.1128/JCM.01885-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

Review 1.  Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.

Authors:  Nira R Pollock
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Contamination of the Hospital Environment From Potential Clostridium difficile Excretors Without Active Infection.

Authors:  Jason S Biswas; Amita Patel; Jonathan A Otter; Esther van Kleef; Simon D Goldenberg
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-10       Impact factor: 3.254

3.  Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Authors:  J L Leslie; S H Cohen; J V Solnick; C R Polage
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 3.267

Review 4.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

6.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

7.  Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.

Authors:  Léa-Laurence Dionne; Frédéric Raymond; Jacques Corbeil; Jean Longtin; Philippe Gervais; Yves Longtin
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

8.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

9.  Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Authors:  Carolyn V Gould; Jonathan R Edwards; Jessica Cohen; Wendy M Bamberg; Leigh Ann Clark; Monica M Farley; Helen Johnston; Joelle Nadle; Lisa Winston; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 20.999

10.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071

View more
  8 in total

1.  High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.

Authors:  Marie L Landry; Jeffrey E Topal; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Johanna Sandlund
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection.

Authors:  Fred C Tenover; David H Persing; Ferric Fang
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Reply to Tenover et al., "Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection".

Authors:  Johanna Sandlund; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.

Authors:  Matthew M Hitchcock; Marisa Holubar; Catherine A Hogan; Lucy S Tompkins; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay.

Authors:  Glen Hansen; Stephen Young; Alan H B Wu; Emily Herding; Vickie Nordberg; Ray Mills; Christen Griego-Fullbright; Aaron Wagner; Chui Mei Ong; Shawna Lewis; Joseph Yoon; Joel Estis; Johanna Sandlund; Emily Friedland; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 6.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

7.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

8.  Discordant Clostridioides difficile diagnostic assay and treatment practice: a cross-sectional study in a tertiary care hospital, Geneva, Switzerland.

Authors:  Lauriane Lenggenhager; Marie-Céline Zanella; Antoine Poncet; Laurent Kaiser; Jacques Schrenzel
Journal:  BMJ Open       Date:  2020-09-13       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.